TANG CAPITAL PARTNERS LP 13D and 13G filings for Aptevo Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-26 1:00 pm Sale | 2021-11-23 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 0 0.000% | -28 (Position Closed) | Filing |
| 2021-11-22 5:28 pm Sale | 2021-11-18 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 28 18.800% | -26 (-47.65%) | Filing |
| 2021-06-21 09:00 am Unchanged | 2021-06-21 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 54 39.600% | 0 (Unchanged) | Filing |
| 2021-02-09 08:30 am Unchanged | 2021-02-09 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 54 40.200% | 0 (Unchanged) | Filing |
| 2020-11-18 5:03 pm Unchanged | 2020-11-03 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 54 42.500% | 0 (Unchanged) | Filing |
| 2020-11-06 4:52 pm Purchase | 2020-11-03 | 13D | Aptevo Therapeutics Inc. APVO | TANG CAPITAL PARTNERS LP | 54 54.400% | 54 (New Position) | Filing |